Toxoplasmic encephalitis (TE) is a life-threatening disease of immunocompromised individuals and has increased in prevalence as
In individuals with functional immune systems, infection by
Toxoplasma gondii is limited by a strong innate and acquired T-cell-mediated immune response. This response drives the actively replicating tachyzoites to encyst and convert into the quiescent bradyzoite form (10, 11) . The cysts persist in various tissues, including the brain, heart, and skeletal muscle (43) , for the life of the individual. When the immune system is compromised, as during infection with human immunodeficiency virus type 1, toxoplasmic encephalitis (TE) occurs as a result of the recrudescence of these cysts and the failure of the host to generate a protective immune response in the brain (25) . TE is frequently a severe life-threatening disease in these individuals. Only approximately one-third of seropositive AIDS patients infected with T. gondii will develop TE (14, 26) . This implies that genetic differences in host resistance may play a role in control of T. gondii infection in the central nervous system (CNS) and supports the importance of understanding these differences.
Inbred mice have been used to determine what immunological parameters are important in the development of resistance to TE (3, 8, 18, 42) . In these mice, initial infection with T. gondii stimulates interleukin-12 (IL-12) production, probably from dendritic cells in the spleen (35) . Stimulation with IL-12 and tumor necrosis factor alpha (TNF-␣) results in the production of gamma interferon (IFN-␥) by natural killer (NK) cells (39, 49) and, in the later stages of infection, by CD4 ϩ and CD8 ϩ T cells (12) . IFN-␥ plays a major role in the control of both acute infection and reactivation of latent cysts in the brain (40, 41) . IFN-␥ stimulation of cells of the macrophage lineage results in secretion of TNF-␣, and synergistic stimulation by IFN-␥ and TNF-␣, rather than cytotoxic effector functions, is critical for host resistance (22, 49) . Yap and Sher have demonstrated that both hematopoietic and nonhematopoietic cells act as IFN-␥-and TNF-␣-dependent effectors of resistance to T. gondii (48) . Generation of reactive nitrogen intermediates, such as nitric oxide (NO), through stimulation of inducible nitric oxide synthase (iNOS) by IFN-␥ and TNF-␣ is one of the major mechanisms of resistance to parasitic infection in hematopoietic cells (1, 6, (19) (20) (21) of TE-susceptible mice. IFN-␥ also acts in concert with IL-1 or IL-6 to stimulate NO production (8, 16, 46) . In addition, NO-independent mechanisms are stimulated by the actions of IFN-␥ in concert with other cytokines. IFN-␥ induces macrophage-mediated killing of intracellular parasites by stimulating increases in the production of reactive oxygen metabolites (28, 30) and inhibits T. gondii replication via induction of indoleamine-2,3-dioxygenase (IDO) and consequent degradation of tryptophan (29, 32) . Additional NO-independent mechanisms that have not yet been identified are involved in resistance of macrophages as well as astrocytes to T. gondii (16, 23) .
Studies with inbred mice have demonstrated that the factors involved in resistance to chronic infection in the CNS differ from those required for resistance to acute infection. The most notable difference in an acute compared to a chronic response appears to be the role of NO. Use of iNOS knockout mice has demonstrated that resistance to acute infection with T. gondii can occur in the absence of NO but that iNOS-deficient mice develop lesions in the CNS and do not survive chronic infec-tion (37). Bohne et al. have proposed a role for NO in triggering conversion of the tachyzoite to the bradyzoite form of T. gondii (2) . This role would be critical in the control of chronic infection in the CNS.
Infection of in vitro cultures of primary astrocytes and microglia has been used to study host resistance to T. gondii in the CNS. Such cultures have demonstrated that astrocytes support growth of the tachyzoite stage and do not mount a NO-dependent defense against the organism (15, 31) . However when astrocytes are stimulated with IFN-␥, T. gondii replication is inhibited via a NO-independent mechanism (16) . Microglial cells, the functional equivalents of macrophages in the CNS, possess an intrinsic NO-dependent inhibitory activity against T. gondii (5, 7).
We have studied mechanisms of resistance to chronic T. gondii infection in the CNS in inbred mice that differ in resistance to TE. To test the hypothesis that microglial cells from TEsusceptible and -resistant mice respond differently to activating cytokines, we isolated primary microglial cells from TE-susceptible CBA/Ca and TE-resistant BALB/c mice and, treating cells from both strains in the same experiment, measured both NO production and the effects of activation on T. gondii replication. This work demonstrated greater NO production in microglia from TE-resistant mice than in those from TE-susceptible mice. A strong correlation was observed between the increased NO production and increased ability to inhibit T. gondii replication in vitro. When microglial cells of both strains were stimulated with IFN-␥ alone, substantial inhibition of T. gondii replication occurred in the absence of NO production, suggesting that this NO-independent mechanism for inhibition of T. gondii replication did not differ between microglia from BALB/c and CBA/Ca mice.
MATERIALS AND METHODS
Reagents. Dulbecco's modified Eagle's medium, 10ϫ minimum essential medium, penicillin-streptomycin, Hanks balanced salt solution, and phosphatebuffered saline used for dissections and cell culture were obtained from Life Technologies (Bethesda, Md.), as were trypsin and IFN-␥. L-Glutamine was obtained from BioWhittaker (Walkersville, Md.). Lipopolysaccharide (LPS) was obtained from List Biologicals (Campbell, Calif.), and TNF-␣ was obtained from R&D Systems (Minneapolis, Minn.)., Catalase and N G -monomethyl-L-arginine (NMMA) was obtained from Calbiochem-Novabiochem (La Jolla, Calif.). Defined fetal bovine serum (FBS) (low endotoxin, lot matched) was obtained from HyClone Laboratories (Logan, Utah). Cytokines for microglial cell culture growth, natural human macrophage colony-stimulating factor 1 (CSF-1), and recombinant murine IL-3 were obtained from Biosource International (Camarillo, Calif.). Benzoic acid (sodium salt), D-mannitol, diazabicyclooctane (DABCO), sulfanilamide, sodium nitrite, and L-tryptophan were purchased from Sigma Chemical Co. (St. Louis, Mo.); N-(1-naphthyl)ethylenediamine dihydrochloride (NEDD) was obtained from Fluka (Ronkonkoma, N.Y.), and [5,6- 3 H]uracil was obtained from Amersham Pharmacia Biotech (Arlington Heights, Ill.).
Primary microglial cultures. Primary cultures of microglial cells were obtained from newborn mice of the BALB/c (Simonsen Laboratories, Gilroy, Calif., and B&K Universal, Fremont, Calif.) and CBA/Ca (B&K Universal) strains by a modification of the method of Chao et al. (4) . Briefly, brains were removed on the day of birth and the neocortices were removed, pooled, minced, and trypsinized (in 0.09% trypsin) for 30 to 45 min at 37°C. The cells were triturated, filtered through a 70-m-pore-size filter, and plated in 75-cm 2 Falcon flasks (VWR Scientific, Chicago, Ill.) in medium stock prepared using minimal essential medium (supplied without bicarbonate or glutamine) and glucose-bicarbonate by the method of Rose et al. (36) . To this preparation were added 20% FBS, 2 mM L-glutamine, penicillin-streptomycin (100 U/ml and 100 g/ml respectively), CSF-1 (0.4 ng/ml), and IL-3 (0.4 ng/ml). The doses of CSF-1 and IL-3 were optimized for these cultures by U. Gawlick (University of Illinois) (personal communication). Cells from three hemispheres were plated per 75-cm 2 flask. Experiments to measure NO production and T. gondii replication were conducted simultaneously on microglia from the two mouse strains. Cells in wells of 96-well plates were stimulated with inducers in groups of eight replicates. After 24 h, four of these wells were infected with T. gondii and an equal volume of medium was added to the four remaining wells. The effects of the inducers on NO production, in the presence or absence of T. gondii, was measured in quadruplicate. In parallel, microglia were plated in identical fashion and assayed for T. gondii replication after 48 h. Wells that did not contain T. gondii were used to establish background incorporation of [ 3 H]uracil. NO measurements. Griess reagents were used to measure nitrite as an indicator of NO in cell culture supernatants (9) . Briefly, 50-l aliquots of cell culture supernatants were added to 96-well plates, followed by 50 l of 1% sulfanilamide in 5% phosphoric acid. After a 10-min incubation at room temperature, 50 l of 0.1% NEDD in water was added, and the incubation was continued for an additional 3 min. Absorbances of the samples were read at 540 nm, using a PowerWave 200 microplate scanning spectrophotometer (BioTek Instruments, Winooski, Vt.), and the nitrite concentration was determined by comparison with a standard curve generated using sodium nitrite in water (concentration range, 0 to 100 M). The absorbance of the blank (consisting of assay medium alone) was subtracted from the value for each sample. Each treatment of microglia was performed in quadruplicate, and each of the wells was assayed in duplicate in the NO assay.
Measurement of T. gondii replication by [ 3 H]uracil incorporation. T. gondii proliferation was determined by measuring [
3 H]uracil incorporation by a micromethod developed by Mack and McLeod (27) Background counts were measured in wells that did not contain T. gondii but were stimulated in parallel. The plates were harvested after 24 h, using a Tomtec harvester and a slow-pulse wash to ensure that all cells were removed from the wells. After the harvest, 50 l of 2.5% trypsin in phosphate-buffered saline was added to the cells remaining in each well and the plates were incubated at 37°C for 10 min. After trypsinization, the cells were again harvested onto the same filter mat by using the Tomtec harvester.
Radioactive counts on filter mats were read in a Betaplate liquid scintillation counter (Wallac Instruments, Gaithersburg, Md.). [ 3 H]uracil incorporation by T. gondii in the presence of NO inducers was compared to incorporation in the absence of inducers in BALB/c and CBA/Ca microglia, and the percent inhibition of T. gondii replication was calculated.
Measurement of the effect of L-tryptophan on IFN-␥-induced inhibition of T. gondii replication. Microglial cells from BALB/c mice were cultured, treated with IFN-␥, and infected with T. gondii as described above. Immediately prior to IFN-␥ addition, increasing concentrations of L-tryptophan in medium were added to quadruplicate wells. Final L-tryptophan concentrations ranged from 2.5 to 160 g/ml. L-Tryptophan was also added to wells in the absence of IFN-␥ to monitor potential toxicity and effect on T. gondii replication. At 24 h after IFN-␥ treatment, the same concentrations of L-tryptophan were again added to each well, along with 10 5 tachyzoites of T. gondii per well. T. gondii replication was measured by [ 3 H]uracil incorporation 24 h after infection, as described above. Measurement of the effect of oxygen scavengers on IFN-␥-induced inhibition of T. gondii replication. Microglial cells from BALB/c mice were cultured, treated with IFN-␥, and infected with T. gondii as described above. At 3 h before addition of T. gondii, the following oxygen scavengers were added to quadruplicate wells by the methods of Woodman et al. (44) : catalase (specific activity, 46,590 U/mg of protein, 16,540 U/mg of material) at final concentrations of 1.15 and 2.3 mg/ml, mannitol at a final concentration of 50 mM, DABCO at 0.5 mM, and benzoic acid at 5 mM. The concentrations initially used by Woodman et al. were modified so that the doses used did not result in toxic effects on T. gondii replication. Fresh dilutions of oxygen scavengers were added immediately before T. gondii addition, and proliferation of T. gondii in the presence of each scavenger was measured by [ 3 H]uracil incorporation 24 h after infection, as described above.
Statistics. Student's t test was used to detect statistically significant differences in NO production between strains for each treatment group in the experiment in Fig. 1 . In the experiment in Fig. 2 , differences between treatments and cells treated with medium were compared using Dunnett's method, and differences between treatments were compared across strains by using analysis of variance (ANOVA). All statistical tests (except two that contained observations of zero concentration of NO) were performed on log-transformed data to stabilize the variance.
RESULTS
Since activation of macrophages is known to require a priming signal from IFN-␥ as well as a triggering signal (13, 21) , cells were treated with the combination of IFN-␥ plus LPS or IFN-␥ plus TNF-␣. As controls, cells were treated with each inducer alone. Finally, cells were treated with LPS plus IFN-␥ plus TNF-␣ to determine whether CBA/Ca microglia under maximal stimulation would produce as much NO as BALB/c microglia did. Since activation with LPS does not occur during infection with T. gondii, treatment with IFN-␥ plus TNF-␣ represents the physiologically relevant activation during T. gondii infection of the CNS. Optimum concentrations of all inducers were determined in preliminary experiments.
Parallel cultures of microglial cells from BALB/c and CBA/ Ca mice were stimulated with 10 ng of LPS per ml, 50 U of IFN-␥ per ml, 100 ng of TNF-␣ per ml, or combinations of these inducers for 48 h. Supernatants were removed from quadruplicate cultures in a 96-well plate and assayed in duplicate for nitrite production, using the Griess reagent. The results of a representative experiment are shown in Fig. 1 .
Microglia from both strains produced significantly higher levels of NO after treatment with LPS, LPS plus IFN-␥, IFN-␥ plus TNF-␣, and LPS plus IFN-␥ plus TNF-␣ than after treatment with medium alone. Microglia from CBA/Ca mice produced consistently less NO than did those from BALB/c mice. This difference was most pronounced (P Ͻ 0.01) after stimulation with LPS or with IFN-␥ plus TNF-␣. In the experiment in Fig. 1 , CBA/Ca microglia produced 33% of the amount of NO produced by microglia from BALB/c cells after stimulation with LPS. In three separate experiments where microglia were cultured for 48 h with LPS, NO production by microglia from CBA/Ca mice ranged between 32 and 35% of that by microglia from BALB/c mice. In two additional experiments where cells were cultured with LPS for 72 h, CBA/Ca microglia produced 56 and 64%, respectively, of the amount of NO produced by BALB/c microglia.
When microglial cells from both strains of mice were stimulated with either IFN-␥ or TNF-␣ alone, insignificant amounts of NO were produced after 48 h. In experiments not shown, treatment with 100 or 500 U of IFN-␥ per ml also did not stimulate significant NO production after 48 h.
When microglia were treated for 48 h with IFN-␥ plus TNF-␣ administered simultaneously, cells from CBA/Ca mice produced only 26% of the amount of NO that was produced by cells from BALB/c mice (P Ͻ 0.01). In three experiments in which cells were cultured for 48 h, the levels of NO produced by CBA/Ca cells ranged between 20 and 30% of the levels observed in BALB/c cells. When cells were stimulated for 72 h with IFN-␥ plus TNF-␣, CBA/Ca microglia produced 46% of the NO that BALB/c microglia produced.
Stimulation with LPS plus IFN-␥ or LPS plus IFN-␥ plus TNF-␣ also resulted in consistently higher levels of NO in cells from BALB/c mice than in cells from CBA/Ca mice; however, differences between the two strains were not as dramatic as when cells were stimulated with either LPS alone or IFN-␥ plus TNF-␣. In three experiments, NO production by CBA/Ca microglia ranged from 53 to 85% of the amount produced by BALB/c microglia after treatment with LPS plus IFN-␥ and from 59 to 79% of the amount produced by BALB/c microglia after treatment with LPS plus IFN-␥ plus TNF-␣.
When microglia from either mouse strain were stimulated with LPS or cytokines for 24 h and then half the cultures were infected with T. gondii and assayed for NO production after an additional 24 h, cells infected with T. gondii showed a significant decrease in NO production compared with cells not infected with T. gondii. This decrease was more pronounced when cells were treated with combinations of inducers that resulted in high levels of NO production, as shown in Table 1 . Infection with T. gondii decreased NO production in cells from both strains of mice.
FIG. 1. NO production by BALB/c and CBA/Ca microglia. Microglia were isolated from newborn BALB/c and CBA/Ca mice as described in Materials and Methods and stimulated with LPS (10 ng/ml), IFN-␥ (50 U/ml), TNF-␣ (100 ng/ml), or combinations of these inducers for 48 h in 96-well plates (4 wells/ treatment group). NO production was measured in supernatants as described in the text. Results are expressed as mean and standard deviation for each treatment and are representative of one of six experiments performed. Student's t test was used to compare differences between strains in the effect of various treatments on NO production. ‫,ءء‬ P Ͻ 0.01.
The role of NO production as a mechanism of resistance against T. gondii infection in the brain has been actively debated (37, 38, 42) . NO production has been thought to be a major mechanism of resistance against parasitic infection in activated macrophages (1) as well as in microglia (6, 7, 20) . To determine whether differences in NO production between microglia from BALB/c and CBA/Ca mice corresponded to differences in the ability of these cells to affect T. gondii replication in vitro, cells were stimulated with NO inducers and then infected with T. gondii. T. gondii replication and NO production were measured in parallel cultures. In all experiments, NO production and Although microglia from both strains of mice did not produce measurable amounts of NO after 48 h stimulation with 50 U of IFN-␥ per ml, substantial inhibition of T. gondii replication occurred after treatment with IFN-␥ in both strains of mice (71% inhibition in BALB/c cells and 64% in CBA/Ca cells). These data suggest that stimulation of microglia with IFN alone results in inhibition of T. gondii replication via a pathway that is NO independent. To further determine the role of NO production in the inhibition of T. gondii replication and to confirm that IFN-␥-mediated inhibition of T. gondii replication was NO independent, cells were treated with cytokines in the presence or absence of the arginine analog NMMA and [
3 H]uracil incorporation by T. gondii was measured. Cells were treated sequentially with 500 M NMMA and NO inducers, allowed to incubate for 24 h, and then infected with T. gondii and given [ 3 H]uracil. After an additional 24-h incubation, both NO production and [
3 H]uracil incorporation were measured. Table 2 shows that addition of NMMA inhibited NO production after treatment with LPS plus IFN-␥ or LPS plus IFN-␥ plus TNF-␣. When NMMA was added to microglia infected with T. gondii in the absence of a Cells were treated for 24 h with 10 ng of LPS per ml, 50 U of IFN-␥ per ml, 100 ng of TNF-␣ per ml, or combinations of these inducers and then infected with 10 5 PLK strain tachyzoites per well, and NO production was measured after an additional 24 h of culture. Results are expressed as mean Ϯ standard deviation. The results shown are from two of six experiments performed. **, statistically significant (P Ͻ 0.01) compared with treatment without T. gondii infection; *, statistically significant (P Ͻ 0.05) compared with treatment without T. gondii infection.
FIG. 2.
T. gondii replication in BALB/c and CBA/Ca microglia. BALB/c and CBA/Ca microglia were isolated as described in Materials and Methods and stimulated in 96-well plates using LPS (10 ng/ml), IFN-␥ (50 U/ml), TNF-␣ (100 ng/ml), or combinations of these inducers. After 24 h, cells were infected with 10 5 PLK strain tachyzoites per well. Control uninfected wells for each treatment received assay medium alone. [ 3 H]uracil was added to all wells (infected and uninfected), and the cells were incubated for an additional 24 h before uracil incorporation was measured. Results are expressed as mean and standard deviation for each treatment and are representative of one of five experiments performed. ANOVA was used to determine differences between strains in the effects of various treatments on uracil incorporation compared to the respective medium controls. ‫,ء‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01. inducers, it had no significant effect on T. gondii replication, demonstrating that NMMA by itself does not adversely affect T. gondii replication. When cells from both mouse strains were treated with IFN-␥ in the presence of NMMA, the inhibition of T. gondii replication that had been previously observed was not reversed, confirming that inhibition of replication by IFN-␥ was independent of NO production.
When cells stimulated with LPS plus IFN-␥ or LPS plus IFN-␥ plus TNF-␣ were treated with 500 M NMMA, [ 3 H] uracil incorporation by T. gondii was significantly increased: fourfold when NMMA was administered in combination with LPS plus IFN-␥ and three-to fourfold when it was administered in combination with LPS plus IFN-␥ plus TNF-␣. However, even with the highest concentrations of NMMA, [ 3 H] uracil incorporation did not return to the levels seen when T. gondii was allowed to replicate in the absence of inducers. The fact that full recovery of T. gondii replication was not seen provides further evidence that an NO-independent mechanism is operating and that this mechanism is activated by the presence of IFN-␥.
IFN-␥ can induce macrophage-mediated killing of intracellular parasites by stimulating increases in the production of reactive oxygen metabolites (28, 30) or inhibiting T. gondii replication via induction of IDO and consequent degradation of tryptophan (29, 32) . The possibility that T. gondii replication was inhibited in BALB/c microglia via either of these mechanisms was investigated. Data presented in Fig. 3 demonstrate that addition of increasing concentrations of tryptophan did not reverse the inhibitory effect of IFN-␥ on T. gondii replication. A series of scavengers of reactive oxygen species were added to microglial cells stimulated with IFN-␥ to determine whether the scavenger molecules blocked the inhibitory effect of IFN-␥ on T. gondii replication. The addition of catalase, mannitol, DABCO, or benzoic acid did not block the inhibitory effects of IFN-␥ (Fig. 4) . These data suggest that the mechanism that contributes to the inhibition of T. gondii replication by IFN-␥ does not involve degradation of L-tryptophan or generation of oxygen radicals.
DISCUSSION
This work demonstrates both NO-dependent and NO-independent mechanisms of inhibition of T. gondii replication in primary microglial cell cultures from newborn BALB/c and CBA/Ca mice. In our studies, microglia from BALB/c mice produced significantly more NO after stimulation with LPS or with IFN-␥ plus TNF-␣ than did microglia from CBA/Ca mice and they inhibited replication of T. gondii to a greater extent. These studies also indicate that an IFN-␥-dependent, NOindependent mechanism exists for inhibition of T. gondii replication in vitro, and from these initial observations, it appears that inhibition of T. gondii replication by this mechanism may not differ significantly between the two mouse strains.
The observed differences in NO production do not appear to be due to trivial differences in treatment of cells from the two strains, since all procedures for dissections, growth of the cells, and assays were performed at the same times and with the same reagents for both strains. Microscopic examination of cells from the two strains did not suggest that major differences in growth rates or viability contributed to differences in NO production or uracil incorporation by T. gondii. When microglia from the two strains were tested for their ability to inhibit T. gondii replication in the presence of IFN-␥ only, no NO was detected; however, T. gondii replication was inhibited to a similar extent in cultures from both strains.
In the present study, we observed that IFN-␥ alone did not induce iNOS expression, even when the concentration was increased to 500 U/ml. Xie et al. (45) and Lowenstein et al. (24) have investigated the molecular basis of the inability of IFN-␥ to induce the full transcriptional response of the iNOS promoter. The murine iNOS promoter from RAW 264.7 cells, of BALB/c origin, has been sequenced, and various regulatory elements in the region have been identified; they include several copies of IFN-␥ response elements, NF-B and AP-1 sites, and TNF-␣ response elements, as well as other elements. Lowenstein et al. (24) , using a luciferase reporter assay, observed that maximal expression of iNOS depended on two discrete regulatory regions upstream of the TATA box: region I (positions Ϫ48 to Ϫ209), which contained LPS response elements, and region II (positions Ϫ913 to Ϫ1029), which alone did not increase the expression of reporter genes but together with region I caused an additional 10-fold increase in reporter gene expression in the presence of IFN-␥. Region II was responsible for IFN-␥-mediated regulation of LPS-induced iNOS, while both regions I and II were necessary for LPS-activated expression. Since the binding of IFN-␥ induced transcription factors to region II of the iNOS promoter is not sufficient to activate gene expression, one would not expect NO production after cells are stimulated in vitro with IFN-␥ alone.
Microglia from BALB/c mice were examined to determine the mechanism whereby treatment with IFN-␥ inhibits T. gondii replication. The inhibition was not due to either degradation of tryptophan or production of oxygen radicals. Tryptophan degradation resulting from IFN-␥ induction of IDO, a tryptophan-decyclizing enzyme, can be overcome by supplementing the medium with increasing amounts of tryptophan. Addition of up to 160 g of tryptophan per ml did not reverse the inhibitory effect of IFN-␥ on [ 3 H]uracil incorporation by T. gondii in the microglial cultures.
T. gondii is susceptible to toxicity mediated by reactive oxygen intermediates in certain in vitro macrophage cultures. The use of catalase to break down hydrogen peroxide and of mannitol, benzoic acid, and the superoxide anion scavenger (DABCO) to scavenge hydroxyl free radicals and reactive oxygen species had no effect on the IFN-␥-mediated inhibition of T. gondii replication in these microglial cell cultures. Thus, we concluded that in this system the inhibitory effect of IFN-␥ on T. gondii replication was not due to the activity of IDO or oxygen free radicals.
Pfefferkorn and Guyre (34) have shown that 128 U of IFN-␥ per ml has no direct effect on T. gondii viability in vitro. Leenen et al. (23) showed that IFN-␥ plus TNF-␣ stimulated a macrophage precursor line to kill Listeria monocytogenes in a NOindependent manner and speculated that the mechanism involved might be phagocytosis of the parasite by the activated macrophage. Microglia, as well as activated macrophages, have an intrinsic phagocytosis-mediated defense against T. gondii (31), as well as a NO-dependent pathway. Recently, Halonen et al. (15, 16) have observed that the combination of IFN-␥ with IL-1 or IL-6 significantly inhibited T. gondii growth in cultured astrocytes and showed that the mechanism was independent of NO, tryptophan starvation, oxygen radical production, or iron deprivation. To date, the mechanism of this in vitro IFN-␥-dependent inhibition of T. gondii replication is unknown. Our observation that a similar mechanism operates in microglial cells supports the importance of this mechanism as a protection against T. gondii replication in the CNS.
The relative importance of the NO-dependent and NOindependent mechanisms of inhibiting T. gondii replication during CNS infection in the CBA/Ca and the BALB/c strains is difficult to assess. Recently, a significant amount of information has become available on possible roles of NO-dependent mechanisms of protection in TE-susceptible and -resistant mouse strains.
Mice with a targeted disruption of the iNOS gene on a 129SvEv ϫ C57BL/6 background have been used to demonstrate that while NO is not required for host control of acute infection, it appears to be critical for control of T. gondii replication in the CNS (37) . At 3 to 4 weeks after infection, the iNOS knockout mice succumbed to T. gondii infection, with parasite proliferation and pathologic manifestations in the CNS. NO production, however, is not the only mechanism of resistance in the CNS. Yap and Sher (48) , using iNOS-deficient mice on a C57BL/6 background, made bone marrow chimeras to dissect the roles of hematopoietic and nonhematopoietic cells in control of T. gondii infection in the CNS. These studies demonstrated that NO is required for hematopoietic cell-derived (microglial) effector cell activity against T. gondii but is not required for nonhematopoietic cell-derived activity. This observation corroborates that of Halonen and Weiss (17) that nonhematopoietic astrocytes inhibit T. gondii replication via an NO-independent mechanism.
The role of NO in resistance to T. gondii in the BALB/c (TE-resistant) mouse appears to be very different from that in the C57BL/6 (TE-susceptible) mouse. Recently, Schluter et al. (38) Thus, the recent literature argues against a significant role for NO in the control of a latent infection in the CNS of BALB/c mice, but it supports the requirement for a role of NO in T. gondii control in strains where a chronic persistent infection occurs in the CNS. In this context, CBA/Ca mice, like C57BL/6 mice, experience a persistent chronic infection in the CNS after T. gondii infection (26) . The fact that CBA/Ca mice produce less NO than do strains that contain the infection and allow the development of latency may explain why T. gondii does not establish a latent infection in the CNS of CBA/Ca mice. In keeping with this analysis, Bohne et al. (2) have suggested that the increased NO production by BALB/c microglia may serve to promote the conversion of tachyzoites to bradyzoites observed in this strain.
In conclusion, our work demonstrates that both NO-dependent and NO-independent mechanisms contribute to the inhibition of T. gondii replication in microglial cultures from BALB/c and CBA/Ca mice. The mechanism of the NO-independent inhibition remains to be elucidated; however, this mechanism appears to be equally functional in both the TEsusceptible CBA/Ca mouse and the TE-resistant BALB/c mouse. Microglia from CBA/Ca mice show decreased production of NO and inhibition of T. gondii replication after stimulation with LPS or IFN-␥ plus TNF-␣ compared to microglia from BALB/c mice. To date, this is the first observation of in vitro differences in NO production between microglia from TE-susceptible and TE-resistant mice.
